Jianzhou Huang

发表

Development of DHQ-based chemical biology probe to profile cellular targets for HBV.

Xuechen Li, H. Chow, Yingjun Zhang, 2020, Bioorganic & medicinal chemistry letters.

3-((R)-4-(((R)-6-(2-Bromo-4-fluorophenyl)-5-(ethoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholin-2-yl)propanoic Acid (HEC72702), a Novel Hepatitis B Virus Capsid Inhibitor Based on Clinical Candidate GLS4.

Yunhao Wei, Biao Nie, Yingjun Zhang, 2018, Journal of medicinal chemistry.

Inhibition mechanism and antiviral activity of an α-ketoamide based SARS-CoV-2 main protease inhibitor

X. Xiong, Zi-feng Yang, Tianyu Zhang, 2023, bioRxiv.

Preclinical evaluation of the SARS-CoV-2 Mpro inhibitor RAY1216 shows improved pharmacokinetics compared with nirmatrelvir

Ji-zheng Chen, Chaofeng Long, Haiming Jiang, 2024, Nature microbiology.